Nigeria is one of the most genetically diverse countries on Earth, home to more than 250 ethnolinguistic groups whose genomes carry signatures of ancient migrations, long-term adaptation to tropical diseases, and evolutionary pressures stretching back hundreds of thousands of years. That diversity matters far beyond ancestry testing. It shapes vulnerability to conditions like sickle cell disease, hypertension, and uterine fibroids, affects how individuals metabolize common medications, and holds clues to evolutionary events still being pieced together. Understanding the genetic landscape of Nigeria is increasingly recognized as essential for global health equity, yet much of genomics research has historically focused on European-descent populations.
Population Structure Within Nigeria
Nigeria’s genetic map does not break down neatly along political or even purely linguistic lines, but broad patterns exist. A whole-genome sequencing study of 449 Nigerians identified three distinct genetic clusters. One grouped Yoruba, Ibibio, Bini, Igbo, and Izon populations together. A second cluster contained Ham and Atyap peoples from central Nigeria. A third included Tangale and overlapping northeastern groups like Waja and Bura-Pabir. The more heterogeneous populations were Hausa, Fulani, and Kanuri, whose genetic profiles reflect varying degrees of admixture with populations carrying North African ancestry.1Cell Genomics. Whole-genome sequencing of 449 Nigerian individuals reveals genetic structure and novel variation
Interestingly, genetic boundaries and language boundaries do not always match. In the Cross River region of southeastern Nigeria, which has strikingly high linguistic diversity, researchers found the population to be genetically quite homogeneous across language groups. Gene flow between language communities was estimated at roughly 10% per generation, enough to maintain genetic unity even as languages remained distinct. These Cross River groups could, however, be clearly differentiated from populations in Cameroon, Ghana, and to some extent Igbo communities.2PubMed Central. Little genetic differentiation as assessed by uniparental markers in the presence of substantial language variation in peoples of the Cross River region of Nigeria
This disconnect between language and genes is a useful reminder that cultural identity and biological ancestry tell different stories. Two neighboring groups may speak mutually unintelligible languages yet share a very recent common gene pool, while groups thousands of kilometers apart may carry similar genetic signatures due to ancient migration routes.
Archaic Ancestry and Deep Evolutionary History
Most people have heard that non-African populations carry small amounts of Neanderthal DNA. What is less widely known is that West African populations carry genetic material from an entirely different archaic lineage, a so-called “ghost population” that has no known fossil record. Statistical modeling of West African genomes suggests that this unknown hominin group split from the shared ancestor of Neanderthals and modern humans somewhere between 360,000 and over a million years ago, and then interbred with the ancestors of present-day Africans sometime within the last 124,000 years. The estimated contribution ranges from about 2% to 19% of ancestry.3PubMed Central. Recovering signals of ghost archaic introgression in African populations
More recent computational methods applied to the 1000 Genomes dataset have continued to support these findings, recovering ghost admixture signals from uncharacterized hominins in both African and non-African populations.4PubMed. Recovering signatures of archaic hominin introgression using ancestral recombination graphs The practical significance is still being worked out, but at minimum it means the story of human evolution in Africa was far more complex than a single linear progression. Multiple hominin lineages coexisted, met, and mixed on the continent for hundreds of thousands of years.
On a more recent timescale, the Bantu expansion left a deep mark on West and Central African genetics. Population modeling using genetic data estimates that Bantu-speaking groups began expanding roughly 5,600 years ago from a relatively small founding population of about 2,200 individuals. Non-Bantu groups in the region showed signs of a slightly older expansion, starting around 7,400 years ago from a similarly small population.5PubMed Central. Genetic variation reveals large-scale population expansion and migration during the expansion of Bantu-speaking peoples These expansions shaped the genetic structure of much of sub-Saharan Africa and are part of the reason that groups as geographically separated as southern Nigerians and southern Africans can share detectable genetic ancestry.
Sickle Cell and Other Malaria Defenses
The sickle cell trait is probably the most widely known example of a genetic adaptation to infectious disease, and Nigeria sits at the center of the story. The country has one of the highest frequencies of the sickle hemoglobin gene (HbS) in the world, maintained by the survival advantage it gives against severe malaria when present in a single copy. A study in the Sudan savanna zone of Nigeria estimated that people carrying one copy of the sickle gene had a fitness advantage of about 21% over those with two normal copies, driven by reduced malaria parasite density rather than by increased fertility or high mutation rates.6PubMed. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival
A large study of Nigerian children confirmed the protective effect from a clinical angle, finding that carriers of one sickle copy had roughly half the odds of developing severe malaria compared to children with normal hemoglobin. Among those who did develop severe malaria, sickle cell carriers also had significantly lower parasite counts in their blood.7PubMed. Association of the sickle cell trait and the ABO blood group with clinical severity of malaria in southwest Nigeria
Sickle cell is not the only red blood cell variant shaped by malaria pressure. Glucose-6-phosphate dehydrogenase (G6PD) deficiency, an enzyme shortage that makes red blood cells more fragile, is also common in Nigerian populations. In a study from Calabar, Nigeria, G6PD deficiency was found in about 18% of the study population, and individuals carrying the sickle trait or sickle cell disease had lower rates of the deficiency than those with normal hemoglobin, suggesting the two protective mechanisms may not co-occur as often.8PubMed Central. Hemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency Coinheritance in AS and SS Individuals in Malaria-Endemic Region: A Study in Calabar, Nigeria A separate study in Jos, Northcentral Nigeria, found G6PD deficiency in 49% of children sampled, with high rates of co-occurrence with malaria.9PubMed Central. Evaluation of the impact of malaria and erythrocyte G6PD deficiency on anaemia outcomes among children in Jos Northcentral Nigeria The wide variation in reported prevalence between regions underscores just how genetically heterogeneous Nigeria is, even for a single well-studied trait.
Another malaria defense widespread in West African populations is Duffy negativity. The Duffy antigen is a protein on red blood cells that the malaria parasite Plasmodium vivax uses as an entry point. A genetic variant that silences expression of this protein on red cells is found at very high frequency across West Africa, effectively blocking P. vivax infection. A study in Ghana, Nigeria’s western neighbor with closely related populations, found that the vast majority of people carried the Duffy-negative genotype and detected zero cases of P. vivax malaria.10PubMed Central. High frequency of the Duffy-negative genotype and absence of Plasmodium vivax infections in Ghana
Beyond Malaria: Sleeping Sickness and Lassa Fever
Malaria is not the only tropical infection that has left its fingerprint on West African genomes. Variants in the APOL1 gene, which are common in people of West African descent, appear to have been selected because they protect against African trypanosomiasis, commonly known as sleeping sickness. These variants, called G1 and G2, allow the body’s trypanosome-killing protein to overcome the evasion strategies of certain parasite subspecies. A case-control study found that the G2 variant provided roughly five-fold protection against infection by one form of sleeping sickness.11PubMed Central. APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
The trade-off is steep. These same APOL1 variants substantially increase the risk of chronic kidney disease. In African American populations, where these variants remain common due to West African ancestry, they are a leading genetic contributor to kidney failure. From an evolutionary standpoint, the benefit of surviving a deadly parasitic infection in youth outweighed the cost of kidney disease in middle age, a grim calculus that natural selection runs without regard for individual well-being.12PubMed Central. Evolution of the primate trypanolytic factor APOL1
Lassa fever, a hemorrhagic virus endemic to West Africa, may have similarly shaped the genome. Genome-wide scans have identified signs of positive selection in two genes implicated in Lassa virus infection and immunity: LARGE, which the virus uses to enter cells, and IL21, involved in immune response. The selected variants appear to affect gene regulation rather than the protein structure itself, potentially altering how strongly these genes are expressed. This suggests that populations in Lassa-endemic regions may have evolved partial resistance to severe disease over generations of exposure.13PubMed Central. Genome-wide scans provide evidence for positive selection of genes implicated in Lassa fever
Lactase Persistence, Salt Sensitivity, and Dietary Adaptation
Not all genetic adaptations in Nigerian populations involve fighting pathogens. Some reflect dietary and environmental pressures. The Fulani, a traditionally pastoralist people who stretch across the West African Sahel and into northern Nigeria, carry a lactase persistence mutation that allows them to digest milk into adulthood. This European-origin variant occurs in Fulani communities at frequencies ranging from about 18% to 60%, and shows signatures of strong recent positive selection, consistent with the advantage of being able to consume dairy in a herding society.14PubMed Central. Population history and genetic adaptation of the Fulani nomads: inferences from genome-wide data and the lactase persistence trait15PubMed Central. Genetic origins of lactase persistence and the spread of pastoralism in Africa Most non-Fulani Nigerian populations, like the majority of people worldwide, lose the ability to digest lactose after childhood.
Salt handling is another area where latitude and climate have left genetic marks. Populations living near the equator, including most Nigerians, tend to carry higher frequencies of gene variants associated with salt and water retention. One well-studied example involves CYP3A5, where the ancestral allele, which promotes salt retention, is most common near the equator and declines as you move toward the poles. A similar pattern holds for the GNB3 825T variant, which appears at a frequency of about 82% in African populations compared to roughly 31% in Europeans.16Human Molecular Genetics. Evolutionary forces in diabetes and hypertension pathogenesis in Africans In ancestral environments where sweating was constant and dietary salt was scarce, retaining sodium was a survival advantage. In modern environments with abundant processed food and salt, those same variants contribute to higher rates of hypertension.
The “slavery hypertension hypothesis,” which proposed that the transatlantic Middle Passage created a genetic bottleneck specifically selecting for extreme salt retention in African Americans, has been influential but remains debated. The original framing argued that the brutal conditions of the slave trade favored individuals who could conserve salt and water.17PubMed. An evolutionary perspective on salt, hypertension, and human genetic variability More recent work suggests that the high frequency of salt-retaining variants in African populations is better explained by long-term adaptation to equatorial climates across the entire continent, predating the slave trade by tens of thousands of years. The distinction matters for how clinicians think about hypertension risk in people of African descent.
Skin Pigmentation Is More Complicated Than It Looks
Skin color in African populations has long been treated as a relatively simple genetic trait. Recent research has upended that assumption. A major study of ethnically diverse African genomes identified variants in or near several genes significantly associated with pigmentation, including SLC24A5, MFSD12, DDB1, and OCA2. At most of these loci, the variants associated with dark pigmentation in Africans turned out to be identical by descent in South Asian and Australo-Melanesian populations, suggesting they are ancient and were present before modern humans left Africa.18PubMed Central. Loci associated with skin pigmentation identified in African populations
Work on the KhoeSan populations of southern Africa, who have considerably lighter skin than equatorial Africans, showed that pigmentation is highly heritable but that known pigmentation genes explain only a small fraction of the variation. Baseline skin color turned out to behave as a complex, polygenic trait with genetic architecture that varies by latitude.19PubMed Central. An Unexpectedly Complex Architecture for Skin Pigmentation in Africans Genes like MFSD12 and DDB1, whose roles in pigmentation were first identified in African populations, have been flagged as areas of ongoing research.20PubMed Central. Evolutionary genetics of skin pigmentation in African populations The broader point is that the full genetics of human pigmentation is nowhere close to mapped out, and African populations hold many of the missing pieces.
The Igbo-Ora Twinning Phenomenon
Nigeria, and the Yoruba people in particular, have long been recognized as having one of the highest rates of twin births in the world. Research has confirmed that this elevated rate is driven specifically by dizygotic (fraternal) twins, meaning multiple eggs are released and fertilized, rather than a single embryo splitting. Placentation and zygosity analyses showed higher proportions of dizygotic twins and trizygotic triplets compared to European populations.21PubMed. The Yoruba contribution to our understanding of the twinning process
The town of Igbo-Ora in Oyo State has become world-famous for its exceptionally high twinning rate, attracting both scientific interest and tourism. Local explanations range from divine blessing to diet, particularly the consumption of certain yam species rich in phytoestrogens. Researchers have weighed these narratives against biomedical evidence, considering factors like maternal age, parity, genetic variants affecting gonadotropin hormones, and the potential role of dietary compounds.22PubMed. Genetics, Diet or Divine Blessing? Local and Scientific Explanations for High Dizygotic Twinning in Igbo-Ora, Nigeria The honest answer is that no single factor has been definitively identified. The phenomenon likely reflects a combination of genetic predisposition and environmental influences that researchers are still pulling apart.
How Drug-Metabolizing Genes Differ in Nigerian Populations
One of the most practically consequential areas of Nigerian genetic research is pharmacogenomics: understanding how genetic variation affects drug response. Nigerian populations carry distinct frequencies of key drug-metabolizing enzyme variants, and these frequencies often differ substantially from the European and East Asian populations on which most drug dosing guidelines were developed.23PubMed. Pharmacogenomics in the Nigerian population: the past, the present and the future
A concrete example involves the CYP3A5 enzyme, which metabolizes a wide range of drugs including immunosuppressants used after organ transplants, certain cancer therapies, and common blood pressure medications. In a study of Nigerians, roughly 60% carried at least one variant affecting CYP3A5 activity. The CYP2C8 enzyme, important for metabolizing the antimalarial drug amodiaquine among other compounds, showed the *2 variant at a frequency of about 19%, while the *3 variant common in European populations was not detected at all.24PubMed. Polymorphisms in CYP2C8 and CYP3A5 genes in the Nigerian population These differences can mean that standard drug doses are too high for some people and too low for others, with real consequences for treatment outcomes. This is not hypothetical: it is the kind of variation that causes side effects in practice when prescribing guidelines developed from one population are applied without adjustment to another.
Uterine Fibroids and Ancestry-Linked Risk
Uterine fibroids affect women of African descent at disproportionately high rates, with earlier onset and higher cumulative risk compared to women of European descent. Research has begun to quantify the genetic component of this disparity. A study comparing ancestry proportions in women with and without fibroids found that among Black women, West African ancestry was associated with increased fibroid risk, while Northern and Southern European ancestry proportions were protective. East African ancestry was specifically associated with a greater chance of developing multiple fibroids.25PubMed Central. Evidence that geographic variation in genetic ancestry associates with uterine fibroids These findings do not identify specific genes but establish that the risk disparity has a genuine genetic basis rather than being purely environmental. Future work in Nigerian and other West African cohorts may help pinpoint the responsible variants.
Blood Group Quirks and Transfusion Implications
Nigerian populations harbor blood group variation that has direct implications for transfusion medicine. A study of pregnant women in Port Harcourt found the most common Rh phenotype to be Dccee at about 26%, with some uncommon and rare Rh phenotypes, including Rh-null (where all Rh antigens are absent), detected at about 2% of the sample. This was one of the first reports of Rh-null in a Nigerian study population.26Journal of Blood Disorders and Transfusion. Uncommon Rh Phenotypes in a Cross Section of Nigerian Antenatal Women: Implications for Molecular Genotyping of Blood Groups
Separately, research into weak D phenotypes, where the Rh D antigen is present but at reduced levels, found that 75% of weak D samples in a Nigerian population were weak D type 4, a variant more common in people of African descent. Standard blood typing methods can misclassify these individuals as Rh-negative, leading to unnecessary anti-D immunoglobulin treatment in pregnancy or, in rarer scenarios, transfusion complications.27Hematology, Transfusion and Cell Therapy. High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited setting Molecular genotyping, rather than relying solely on serological testing, would improve accuracy but remains expensive and uncommon in many Nigerian healthcare settings.
The Nigerian 100K Genome Project
Much of what is described above comes from studies of a few hundred or at most a few thousand participants. The Nigerian 100K Genome Project, formally called the Non-Communicable Diseases Genetic Heritage Study (NCD-GHS), aims to change that scale dramatically by sequencing the genomes of 100,000 Nigerian adults.28Nature Genetics. Promoting the genomic revolution in Africa through the Nigerian 100K Genome Project The project’s goals include building a comprehensive catalog of genetic variation across Nigeria’s many ethnolinguistic groups and assessing the genetic underpinnings of non-communicable diseases like diabetes, hypertension, and cancer in the population. Given that Nigerians make up roughly one in five Africans, the dataset would address one of the largest gaps in global genomics and improve the accuracy of polygenic risk scores, drug response predictions, and ancestry analyses for hundreds of millions of people.